@Stickshift
I'm not sure that folks think US listing results in auto-magic SP soaring. I've only ever seen posters here, myself included, provide –or at least infer– reasons specific to IHL as to why IHL's price should soar.
The only real question I have is how much the Australian market will anticipate the US listing rerate. I think it could range from a modest rise on the ASX prior to dual listing, all the way to a very significant rise, maybe up into the mid 40's, perhaps higher. The trigger should be once the BOD announces their concrete plan, along with precise timing information.
Even if the Australian market catches on more than I'm giving it credit for, and the SP reaches into the 50s before dual listing, I think in the weeks following dual listing, we'd see a further 20-50% rise, perhaps more.
Some of this depends on the news flow the company will have up its sleeves. I think anyone who has spent any time following the moves of this company's board understands the likelihood that they fully appreciate the importance of the ammunition they have for a NASDAQ listing send off.
The one reservation I personally have is if there is no OSA Phase 2b trial update between now and then. Again, I think the BOD knows full well how much of a liability that would represent and so I feel very confident they've got that covered, or will not dual list until they do.
None of this is financial advice.
